About Hefei Lifeon Pharmaceutical Company

The company was founded in 2002 and successfully listed on the main board of the Shenzhen Stock Exchange on December 15, 2020. Adhering to the concept of “innovation is the highest efficiency of an enterprise”, the company has established an osmosis pump controlled release technology platform composed of four major components: formulation technology, formulation engineering technology, and key equipment technology, and has continuously improved osmosis pump formulation product development and industrialization capabilities. The company's main business includes the pharmaceutical industry and pharmaceutical business. The company's main products include oxycodone hydrochloride extended-release tablets (10mg, 40mg), methylphenidate hydrochloride extended-release tablets, nifedipine controlled-release tablets, paliperidone sustained-release tablets, felodipine sustained-release tablets, trimetazidine hydrochloride sustained-release tablets, venlafaxine hydrochloride sustained-release tablets, yqi and stomach capsules, galactone capsules, galacontophan capsules, quinine granules, dampicol ointment, criacnidone eye drops liquid etc. Corporate honors: The company has obtained more than 30 invention patents, and has successively won honors such as “National Torch Program Key High-tech Enterprise”, “Anhui Province Innovative Enterprise”, “Provincial Certified Enterprise Technology Center”, “Anhui Pharmaceutical Industry's Most Valuable Investment Enterprise”, “Anhui Drug Retention Engineering Technology Center”, “Hefei Intellectual Property Demonstration Enterprise”, and “Anhui American Brand Demonstration Enterprise” for eight consecutive years.